IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 36 di 36
Titolo Data di pubblicazione Autore(i) File
A modified weekly docetaxel schedule as first-line chemotherapy in elderly metastatic breast cancer: A safety study 1-gen-2005 Maisano, R; Mare, M; Caristi, Nicola; Chiofalo, G; Picciotto, Maria; Carboni, R; Mafodda, A; LA TORRE, Francesco
Safety of Capecitabine plus Bevacizumab in heavily treated patients with metastatic colorectal cancer (MCRC) 1-gen-2007 Adamo, Vincenzo; Festa, V; Restuccia, Eleonora; Chiofalo, G; Maisano, C; Picciotto, Maria; Alafaci, Elisabetta; Tortora, G.
Gefitinib versus Erlotinib treatment in Non Small Cell Lung Cancer (NSCLC): comparison of two clinical experiences. 1-gen-2009 Franchina, Tindara; A., Scimone; Denaro, Nerina; P., Gambadauro; G., Chiofalo; Alafaci, Elisabetta; C., Maisano; Picciotto, Maria; E., Restuccia; G., Toscano; Adamo, Vincenzo
MYELODYSPLASTIC SYNDROMES DEVELOPING DURING IMATINIB THERAPY FOR GIST 1-gen-2010 Buda, Carmelo; C., Arrigo; Picciotto, Maria; Altavilla, Giuseppe; Pitini, Vincenzo
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: 1-gen-2011 Franchina, Tindara; Proto, C; Noto, L; Chiofalo, G; Ferraro, Giuseppa; Picciotto, Maria; Adamo, Vincenzo
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: a case report. 1-gen-2011 Franchina, Tindara; Proto, Claudia; Noto, L; Chiofalo, G; Ferraro, G; Picciotto, Maria; Adamo, V.
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC). 1-gen-2011 Franchina, Tindara; Ferlazzo, Nadia; Colonese, Francesca; Alafaci, Elisabetta; Aquino, A. D'; Ferraro, Giuseppa; Garipoli, Claudia; Maisano, C.; Picciotto, Maria; Curro', Monica; Ientile, Riccardo; Adamo, Vincenzo
Role of virtual colonoscopy following incomplete optical colonoscopy: our experience 1-gen-2011 Salamone, Ignazio; Buda, Carmelo; Arcadi, T; Cutugno, G; Picciotto, Maria
Emerging targeted therapies for castration-resistant prostate cancer 1-gen-2012 Adamo, Vincenzo; Noto, Laura; Franchina, Tindara; Chiofalo, G; Picciotto, Maria; Toscano, G; Caristi, Nicola
Re-treatment with gefitinib or treatment with erlotinib after gefitinib failure in responsive non small cell lung cancers: new strategies to overcome acquired resistance. 1-gen-2013 Franchina, Tindara; Russo, A; Picciotto, Maria; Scimone, A; Berenato, R; Noto, L; Schifano, S; Adamo, Vincenzo
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 1-gen-2013 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Cardia, R.; Ferraro, Giuseppa; Franchina, Tindara; Picciotto, Maria; Zanghi', Mariangela; Trimarchi, Giuseppe; Tuccari, Giovanni; Adamo, Vincenzo
Impact of erlotinib on overall survival in non small cell lung cancer patients: is the post progression survival a new paradigm? 1-gen-2013 Franchina, Tindara; Russo, Alessandro; Proto, C; Chiofalo, G; Picciotto, Maria; Scimone, A; Toscano, G; Berenato, R; Noto, L; Adamo, Vincenzo
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. 1-gen-2014 Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V.
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 1-gen-2017 Russo, Alessandro; Franchina, T.; Ricciardi, G. R. R.; Smiroldo, V.; Picciotto, M.; Zanghì, M.; Rolfo, C.; Adamo, V.
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 1-gen-2017 Picciotto, Maria; Franchina, Tindara; Russo, Alessandro; Ricciardi, Giuseppina Rosaria Rita; Provazza, Giusy; Sava, Serena; Baldari, Sergio; Caffo, Orazio; Adamo, Vincenzo
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario 1-gen-2019 Russo, A.; Franchina, T.; Ricciardi, G.; Battaglia, A.; Picciotto, M.; Adamo, V.
Mostrati risultati da 21 a 36 di 36
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile